| Identification | Back Directory | [Name]
(5E)-BiMatoprost | [CAS]
1163135-95-2 | [Synonyms]
(5E)-BiMatoprost
5-trans-BiMatoprost
5,6-trans-Bimatoprost
Bimatoprost Impurity V
5-trans Bimatoprost-d5
Bimatoprost (5E)-Isomer
5.6 TRANS- BIMATOPROST IMPURITY
Bimatoprost Impurity 2(5-trans Bimatoprost)
Latanoprost and Bimatoprost 5,6-trans-bimatoprost
5-trans-17-phenyl trinor Prostaglandin F2α ethyl amide
5-trans-17-phenyl trinor Prostaglandin F2.alpha. ethyl amide
Latanoprost and Bimatoprost Intermediate 5,6-trans-bimatoprost
(E)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide
(5E)-N-ethyl-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-cyclopentyl]hept-5-enamide
(5E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenaMide
5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5E)-
5-trans-Bimatoprost/(5E)-Bimatoprost/(5E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide | [Molecular Formula]
C25H37NO4 | [MDL Number]
MFCD24386595 | [MOL File]
1163135-95-2.mol | [Molecular Weight]
415.57 |
| Chemical Properties | Back Directory | [Boiling point ]
629.8±55.0 °C(Predicted) | [density ]
1.145±0.06 g/cm3(Predicted) | [storage temp. ]
Amber Vial, -86°C Freezer, Under inert atmosphere | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
14.25±0.20(Predicted) | [color ]
Colourless to Orange Oil to Sticky | [Stability:]
Light Sensitive, Temperature Sensitive | [InChIKey]
AQOKCDNYWBIDND-ABRBVVEGSA-N | [SMILES]
C(NCC)(=O)CCC/C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCC1=CC=CC=C1 |
| Hazard Information | Back Directory | [Uses]
(5E)-BiMatoprost can be used in the improved process for the production and purification of Bimatoprost (B386800).
| [Definition]
ChEBI: 5-trans-17-phenyl trinor Prostaglandin F2alpha ethyl amide is a prostanoid. |
|
|